• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在确证性随机临床试验中分析多个终点——一种针对严格有序结局处理分层、缺失值、基线不平衡和多重性的方法。

Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes.

作者信息

Sun Hengrui, Kawaguchi Atsushi, Koch Gary

机构信息

Department of Biostatistics, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan.

出版信息

Pharm Stat. 2017 Mar;16(2):157-166. doi: 10.1002/pst.1799. Epub 2017 Jan 11.

DOI:10.1002/pst.1799
PMID:28074600
Abstract

Confirmatory randomized clinical trials with a stratified design may have ordinal response outcomes, ie, either ordered categories or continuous determinations that are not compatible with an interval scale. Also, multiple endpoints are often collected when 1 single endpoint does not represent the overall efficacy of the treatment. In addition, random baseline imbalances and missing values can add another layer of difficulty in the analysis plan. Therefore, the development of an approach that provides a consolidated strategy to all issues collectively is essential. For a real case example that is from a clinical trial comparing a test treatment and a control for the pain management for patients with osteoarthritis, which has all aforementioned issues, multivariate Mann-Whitney estimators with stratification adjustment are applicable to the strictly ordinal responses with stratified design. Randomization based nonparametric analysis of covariance is applied to account for the possible baseline imbalances. Several approaches that handle missing values are provided. A global test followed by a closed testing procedure controls the family wise error rate in the strong sense for the analysis of multiple endpoints. Four outcomes indicating joint pain, stiffness, and functional status were analyzed collectively and also individually through the procedures. Treatment efficacy was observed in the combined endpoint as well as in the individual endpoints. The proposed approach is effective in addressing the aforementioned problems simultaneously and straightforward to implement.

摘要

采用分层设计的验证性随机临床试验可能具有有序反应结果,即有序类别或与区间尺度不兼容的连续测定值。此外,当单一终点不能代表治疗的整体疗效时,通常会收集多个终点。此外,随机基线不平衡和缺失值会给分析计划增加另一层难度。因此,开发一种能为所有问题提供综合策略的方法至关重要。对于一个来自比较试验治疗和对照治疗骨关节炎患者疼痛管理的临床试验的实际案例,该试验存在上述所有问题,具有分层调整的多变量曼 - 惠特尼估计器适用于分层设计的严格有序反应。基于随机化的非参数协方差分析用于处理可能的基线不平衡。提供了几种处理缺失值的方法。在对多个终点进行分析时,先进行全局检验,然后采用封闭检验程序在强意义上控制家族性错误率。通过这些程序对表明关节疼痛、僵硬和功能状态的四个结果进行了集体分析和单独分析。在综合终点以及各个终点均观察到了治疗效果。所提出的方法能有效同时解决上述问题且易于实施。

相似文献

1
Analyzing multiple endpoints in a confirmatory randomized clinical trial-an approach that addresses stratification, missing values, baseline imbalance and multiplicity for strictly ordinal outcomes.在确证性随机临床试验中分析多个终点——一种针对严格有序结局处理分层、缺失值、基线不平衡和多重性的方法。
Pharm Stat. 2017 Mar;16(2):157-166. doi: 10.1002/pst.1799. Epub 2017 Jan 11.
2
Sensitivity analysis for missing dichotomous outcome data in multi-visit randomized clinical trial with randomization-based covariance adjustment.在基于随机化协方差调整的多次访视随机临床试验中,对二分缺失结局数据的敏感性分析。
J Biopharm Stat. 2017;27(3):387-398. doi: 10.1080/10543406.2017.1289955. Epub 2017 Feb 8.
3
Multivariate Mann-Whitney estimators for the comparison of two treatments in a three-period crossover study with randomly missing data.用于在具有随机缺失数据的三周期交叉研究中比较两种治疗方法的多变量曼-惠特尼估计量。
J Biopharm Stat. 2010 Jul;20(4):720-44. doi: 10.1080/10543401003618108.
4
Statistical planning in confirmatory clinical trials with multiple treatment groups, multiple visits, and multiple endpoints.具有多个治疗组、多次访视和多个终点的验证性临床试验中的统计设计。
J Biopharm Stat. 2018;28(1):189-211. doi: 10.1080/10543406.2017.1378664. Epub 2017 Nov 6.
5
Statistical planning to address strongly correlated endpoints for inferential subgroups: An innovative approach for an illustrative clinical trial with complex multiplicity issues.针对推理亚组中强相关终点的统计规划:一种用于具有复杂多重性问题的说明性临床试验的创新方法。
J Biopharm Stat. 2017;27(3):399-415. doi: 10.1080/10543406.2017.1289945. Epub 2017 Feb 10.
6
Addressing multiplicity issues of a composite endpoint and its components in clinical trials.解决临床试验中复合终点及其组成部分的多重性问题。
J Biopharm Stat. 2011 Jul;21(4):610-34. doi: 10.1080/10543406.2011.551327.
7
Multiple contrast tests for multiple endpoints in the presence of heteroscedasticity.存在异方差性时针对多个终点的多重对比检验。
Int J Biostat. 2014;10(1):17-28. doi: 10.1515/ijb-2012-0015.
8
Penalty-based approaches to evaluating multiplicity adjustments in clinical trials: Advanced multiplicity problems.基于惩罚的临床试验多重性调整评估方法:高级多重性问题。
J Biopharm Stat. 2018;28(1):169-188. doi: 10.1080/10543406.2017.1397011. Epub 2017 Nov 10.
9
How to deal with multiple endpoints in clinical trials.如何处理临床试验中的多个终点。
Fundam Clin Pharmacol. 2006 Dec;20(6):515-23. doi: 10.1111/j.1472-8206.2006.00437.x.
10
Easily applicable multiple testing procedures to improve the interpretation of clinical trials with composite endpoints.易于应用的多重检验程序,以改善对具有复合终点的临床试验的解读。
Int J Cardiol. 2014 Jul 15;175(1):126-32. doi: 10.1016/j.ijcard.2014.04.267. Epub 2014 May 9.